Solana’s SOL has rebounded from support near $100 as traders watch for a recovery toward $150 and beyond, while onchain metrics show record activity.

The SOL/BTC pair broke a long-held support level as analysts tracked growing weakness against Bitcoin while banks assessed Solana’s longer-term role in micropay ...

A “short attack” is a campaign in which a short seller publishes a critical report about a target company in order to profit from the ensuing ...

Nobel laureate Jennifer Doudna, PhD; Matthew Porteus, MD, PhD, and Rodolphe Barrangou, PhD—offer their views on the commercial potential and challenges of genome editing following a rollercoaster 2025 ...

Adjusted EPS guidance for 2026 is $13.60 to $15.00, with Rodriguez highlighting, “This guidance exceeds our long-term EPS targets, reflecting our expectation for another year of strong operating ...

Rather than grading only final essays or presentations, Bond evaluates each stage of the writing process.

Clarke’s feature article1 on conscientious objection (CO) in healthcare turns the spotlight on a medically relevant and ...

Piper Sandler names Microsoft a top idea After a change in analyst coverage, the firm says shares of Microsoft are best positioned for AI. "We see Microsoft as perhaps the best pure-play on AI ...

Clear Street Group Inc. has filed for an initial public offering that could raise up to $1.05 billion, as the cloud-native Wall Street brokerage prepares to test investor appetite for next-generation ...

In late January 2026, Whirlpool Corporation reported fourth-quarter 2025 results showing sales of about US$4.10 billion and a ...

Society as a whole is experiencing a shift towards winner-take-most environments, with crypto traders now preferring rapid ...

Korro Bio (NASDAQ:KRRO) used its Analyst Day to outline the rationale and development plans for KRRO-121, an RNA-editing therapeutic candidate the company believes could provide a new approach to ...